Core Scientific, Inc./tx (CORZ): auditor change — Core Scientific confirms Marcum as new independent auditor for FY2022 after EY dismissal

Core Scientific, Inc./tx

Marcum LLP completed client acceptance procedures on Nov 22, 2022, finalizing appointment as auditor for FY2022.
EY was dismissed on Oct 24, 2022, effective upon filing of Q3 2022 10-Q.
No disagreements or reportable events existed with EY during fiscal 2020 and 2021.
Marcum was not consulted on any accounting or audit matters prior to its appointment.

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Core Scientific, Inc./tx dismissed Ernst & Young LLP as its auditor.

Action: dismissal
Auditor: Ernst & Young LLP
Successor: Marcum LLP

Exact text from the filing

At the same meeting, the Audit Committee approved the dismissal of Ernst & Young LLP ("EY") as independent registered public accounting firm of the Company effective upon the date of the filing of the quarterly report on Form 10-Q for the quarter ending September 30, 2022.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Core Scientific, Inc./tx engaged Marcum LLP as its auditor.

Action: engagement
Auditor: Marcum LLP

Exact text from the filing

on October 24, 2022, the Audit Committee of the Company’s Board of Directors approved the engagement of Marcum LLP ("Marcum") as its independent registered public accounting firm for the fiscal year ending December 31, 2022, subject to Marcum’s completion of their client acceptance procedures.

View on SEC.gov

18 auditor changes filed in the last 30 days. Browse all auditor changes →

Core Scientific, Inc./tx filing history →

Source: SEC EDGAR

accession 0001628280-22-030748

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.